Sunghoon Kwon News Today

QuantaMatrix, an in vitro diagnostics company specializing in the discovery, development and commercialization of fully integrated solutions within the sepsis value chain, today announces that its dRAST™ solution has been adopted for routine clinical use by admed, a Swiss-based laboratory.

/PRNewswire/ -- QuantaMatrix, an in vitro diagnostics company specializing in the discovery, development and commercialization of fully-integrated solutions...

Press release content from PR Newswire. The AP news staff was not involved in its creation.